PE Anti-Human CD273/PD-L2 Antibody[24F.10C12]

Introducing the PE Anti-Human CD273/PD-L2 Antibody [24F.10C12], a cutting-edge product designed to revolutionize the field of immunology. This antibody, with the catalog number E-AB-F1175D-200Tests, offers a remarkable solution for researchers and scientists seeking to explore the intricate mechanisms of immune regulation.

The PE Anti-Human CD273/PD-L2 Antibody [24F.10C12] is meticulously crafted to exhibit exceptional specificity and sensitivity, ensuring accurate and reliable results in a wide range of applications. With its advanced formulation, this antibody enables the precise detection and analysis of CD273/PD-L2, a crucial immune checkpoint molecule involved in immune response modulation.

This product is meticulously manufactured using state-of-the-art techniques, guaranteeing exceptional quality and consistency. Each batch undergoes rigorous quality control measures to ensure optimal performance and reproducibility, providing researchers with the utmost confidence in their experimental outcomes.

The PE Anti-Human CD273/PD-L2 Antibody [24F.10C12] is supplied in a convenient format of 200 tests, allowing for ample experimentation and analysis. Its compatibility with various experimental techniques, such as flow cytometry, immunohistochemistry, and immunofluorescence, further enhances its versatility and applicability in diverse research settings.

Researchers can rely on the PE Anti-Human CD273/PD-L2 Antibody [24F.10C12] to unlock new insights into immune regulation, paving the way for groundbreaking discoveries and advancements in the field. Its exceptional performance, combined with its user-friendly format, makes it an indispensable tool for immunologists and scientists alike.

Choose the PE Anti-Human CD273/PD-L2 Antibody [24F.10C12] with confidence, and embark on a journey of scientific exploration and innovation. Elevate your research to unprecedented heights with this remarkable antibody, and unravel the complexities of immune regulation like never before.